Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience

Research output: Contribution to journalArticle

Abstract

Chronic migraine is a common and debilitating headache syndrome. Botulinum neurotoxin, a potent toxin produced by the anaerobic bacterium clostridium botulinum, used largely for treatment of disorders associated with increased muscle tone and hyperhidrosis, is used for patients suffering from chronic migraine. In this study, a group of patients suffering from chronic migraine with medication overuse was treated with onabotulinum toxin A (Botox) to verify its efficacy for chronic migraine. The results confirmed the efficacy of onabotulinum toxin A (Botox) when used at the dosage of 155 UI according to the PREEMPT protocol. Although these results are preliminary, they led to intense efforts to evaluate the analgesic properties of onabotulinum toxin A (Botox) and to assess its use in clinical practice, in particular in migraine field.

Original languageEnglish
Pages (from-to)33-35
Number of pages3
JournalNeurological Sciences
Volume36
DOIs
Publication statusPublished - May 30 2015

Fingerprint

Migraine Disorders
Therapeutics
Muscle Hypertonia
Clostridium botulinum
Hyperhidrosis
Headache Disorders
Anaerobic Bacteria
Neurotoxins
Analgesics
onabotulinumtoxinA

Keywords

  • Chronic migraine (CM) with medication overuse (MO)
  • Onabotulinum toxin A (Botox)
  • PREEMPT study

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Onabotulinum toxin A (Botox) for chronic migraine treatment : an Italian experience. / Grazzi, L.; Usai, S.

In: Neurological Sciences, Vol. 36, 30.05.2015, p. 33-35.

Research output: Contribution to journalArticle

@article{7d3d64d4b8914433be97706d4f12866e,
title = "Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience",
abstract = "Chronic migraine is a common and debilitating headache syndrome. Botulinum neurotoxin, a potent toxin produced by the anaerobic bacterium clostridium botulinum, used largely for treatment of disorders associated with increased muscle tone and hyperhidrosis, is used for patients suffering from chronic migraine. In this study, a group of patients suffering from chronic migraine with medication overuse was treated with onabotulinum toxin A (Botox) to verify its efficacy for chronic migraine. The results confirmed the efficacy of onabotulinum toxin A (Botox) when used at the dosage of 155 UI according to the PREEMPT protocol. Although these results are preliminary, they led to intense efforts to evaluate the analgesic properties of onabotulinum toxin A (Botox) and to assess its use in clinical practice, in particular in migraine field.",
keywords = "Chronic migraine (CM) with medication overuse (MO), Onabotulinum toxin A (Botox), PREEMPT study",
author = "L. Grazzi and S. Usai",
year = "2015",
month = "5",
day = "30",
doi = "10.1007/s10072-015-2140-2",
language = "English",
volume = "36",
pages = "33--35",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Onabotulinum toxin A (Botox) for chronic migraine treatment

T2 - an Italian experience

AU - Grazzi, L.

AU - Usai, S.

PY - 2015/5/30

Y1 - 2015/5/30

N2 - Chronic migraine is a common and debilitating headache syndrome. Botulinum neurotoxin, a potent toxin produced by the anaerobic bacterium clostridium botulinum, used largely for treatment of disorders associated with increased muscle tone and hyperhidrosis, is used for patients suffering from chronic migraine. In this study, a group of patients suffering from chronic migraine with medication overuse was treated with onabotulinum toxin A (Botox) to verify its efficacy for chronic migraine. The results confirmed the efficacy of onabotulinum toxin A (Botox) when used at the dosage of 155 UI according to the PREEMPT protocol. Although these results are preliminary, they led to intense efforts to evaluate the analgesic properties of onabotulinum toxin A (Botox) and to assess its use in clinical practice, in particular in migraine field.

AB - Chronic migraine is a common and debilitating headache syndrome. Botulinum neurotoxin, a potent toxin produced by the anaerobic bacterium clostridium botulinum, used largely for treatment of disorders associated with increased muscle tone and hyperhidrosis, is used for patients suffering from chronic migraine. In this study, a group of patients suffering from chronic migraine with medication overuse was treated with onabotulinum toxin A (Botox) to verify its efficacy for chronic migraine. The results confirmed the efficacy of onabotulinum toxin A (Botox) when used at the dosage of 155 UI according to the PREEMPT protocol. Although these results are preliminary, they led to intense efforts to evaluate the analgesic properties of onabotulinum toxin A (Botox) and to assess its use in clinical practice, in particular in migraine field.

KW - Chronic migraine (CM) with medication overuse (MO)

KW - Onabotulinum toxin A (Botox)

KW - PREEMPT study

UR - http://www.scopus.com/inward/record.url?scp=84931259754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931259754&partnerID=8YFLogxK

U2 - 10.1007/s10072-015-2140-2

DO - 10.1007/s10072-015-2140-2

M3 - Article

C2 - 26017508

AN - SCOPUS:84931259754

VL - 36

SP - 33

EP - 35

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -